Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies.

Carboni L, McCarthy DJ, Delafont B, Filosi M, Ivanchenko E, Ratti E, Learned SM, Alexander R, Domenici E.

Transl Psychiatry. 2019 Aug 2;9(1):182. doi: 10.1038/s41398-019-0521-7.

2.

Investigation of mixed model repeated measures analyses and non-linear random coefficient models in the context of long-term efficacy data.

Delafont B, Carroll K, Vilain C, Pham E.

Pharm Stat. 2018 Sep;17(5):515-526. doi: 10.1002/pst.1868. Epub 2018 May 20.

PMID:
29781237
3.

Device errors in asthma and COPD: systematic literature review and meta-analysis.

Chrystyn H, van der Palen J, Sharma R, Barnes N, Delafont B, Mahajan A, Thomas M.

NPJ Prim Care Respir Med. 2017 Apr 3;27(1):22. doi: 10.1038/s41533-017-0016-z. Review.

4.

An investigation of thrust, depth and the impedance cardiogram as measures of cardiopulmonary resuscitation efficacy in a porcine model of cardiac arrest.

Howe A, O'Hare P, Crawford P, Delafont B, McAlister O, Di Maio R, Clutton E, Adgey J, McEneaney D.

Resuscitation. 2015 Nov;96:114-20. doi: 10.1016/j.resuscitation.2015.07.020. Epub 2015 Jul 31.

PMID:
26234892
5.

Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis.

Rennard SI, Locantore N, Delafont B, Tal-Singer R, Silverman EK, Vestbo J, Miller BE, Bakke P, Celli B, Calverley PM, Coxson H, Crim C, Edwards LD, Lomas DA, MacNee W, Wouters EF, Yates JC, Coca I, Agustí A; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints.

Ann Am Thorac Soc. 2015 Mar;12(3):303-12. doi: 10.1513/AnnalsATS.201403-125OC.

PMID:
25642832
6.

Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial.

Roden M, Weng J, Eilbracht J, Delafont B, Kim G, Woerle HJ, Broedl UC; EMPA-REG MONO trial investigators.

Lancet Diabetes Endocrinol. 2013 Nov;1(3):208-19. doi: 10.1016/S2213-8587(13)70084-6. Epub 2013 Sep 9.

PMID:
24622369
7.

Prediction of weight loss and regain following dietary, lifestyle, and pharmacologic intervention.

Napolitano A, Miller SR, Murgatroyd PR, Delafont B, Brooke A, Elkhawad M, Tan CY, Virtue S, Vidal-Puig A, Nunez DJ.

Clin Pharmacol Ther. 2012 Jun;91(6):1027-34. doi: 10.1038/clpt.2011.333. Epub 2012 Feb 15.

PMID:
22336590
8.

Pragmatic study of orlistat 60 mg on abdominal obesity.

Thomas EL, Makwana A, Newbould R, Rao AW, Gambarota G, Frost G, Delafont B, Mishra RG, Matthews PM, Berk ES, Schwartz SM, Bell JD, Beaver JD.

Eur J Clin Nutr. 2011 Nov;65(11):1256-62. doi: 10.1038/ejcn.2011.108. Epub 2011 Jun 22.

PMID:
21697820
9.

Distinct modulatory effects of satiety and sibutramine on brain responses to food images in humans: a double dissociation across hypothalamus, amygdala, and ventral striatum.

Fletcher PC, Napolitano A, Skeggs A, Miller SR, Delafont B, Cambridge VC, de Wit S, Nathan PJ, Brooke A, O'Rahilly S, Farooqi IS, Bullmore ET.

J Neurosci. 2010 Oct 27;30(43):14346-55. doi: 10.1523/JNEUROSCI.3323-10.2010.

Supplemental Content

Loading ...
Support Center